關鍵數據
6.000今開
6.220最高
21.76K成交量
虧損本益比TTM
12.80本益比動
--股利TTM
0.48%換手率
6.090昨收
6.000最低
116.04K成交額
虧損本益比靜
2.74市淨率
0.00%股息率 TTM
-12.41%ROA
9.45852週最高
3.13量比
-12.40M淨利潤
4.51M總股本
-2.1224每股盈餘TTM
1.55Beta
-78.65%ROE
3.10152週最低
3.61%振幅
55.04%毛利率
27.51M總市值
-0.20回報/風險
4.94%風險率
操作建議
Harvard Bioscience Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名106/199位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為6.00。中期看,股價處於平穩狀態。近一個月,市場表現一般,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
Harvard Bioscience Inc評分
壓力支撐

由於公司未披露,未能獲取相關數據
Harvard Bioscience Inc亮點
亮點風險
Harvard Bioscience Inc新聞
即將為您帶來更多新聞,敬請期待。 。 。
收益預測
Harvard Bioscience Inc
HBIO
2
Intuitive Surgical Inc
ISRG
35
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
29
技術指標
財務指標
每股收益

由於公司未披露,未能獲取相關數據
營業總收入

由於公司未披露,未能獲取相關數據
Harvard Bioscience Inc簡介
Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.
公司代碼HBIO
公司Harvard Bioscience Inc
CEODuke (John D)
網址https://www.harvardbioscience.com/
公司股東
常見問題
Harvard Bioscience Inc(HBIO)的當前股價是多少?
Harvard Bioscience Inc(HBIO)的當前股價是 6.21。
Harvard Bioscience Inc 的股票代碼是什麼?
Harvard Bioscience Inc的股票代碼是HBIO。
Harvard Bioscience Inc股票的52週最高點是多少?
Harvard Bioscience Inc股票的52週最高點是9.46。
Harvard Bioscience Inc股票的52週最低點是多少?
Harvard Bioscience Inc股票的52週最低點是3.10。
Harvard Bioscience Inc的市值是多少?
Harvard Bioscience Inc的市值是28.01M。
現在Harvard Bioscience Inc(HBIO)的股票是買入、持有還是賣出?
根據分析師評級,Harvard Bioscience Inc(HBIO)的總體評級為買入,目標價格為6.00。
Harvard Bioscience Inc(HBIO)股票的每股收益(EPS TTM)是多少
Harvard Bioscience Inc(HBIO)股票的每股收益(EPS TTM)是-12.77。